Cargando…
Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis
OBJECTIVE: To evaluate magnetic resonance imaging (MRI) parameters T2 signal, contrast enhancement (CE), and relative liver enhancement (RLE) of extracellular gadolinium-based contrast agent (GBCA)-enhanced MRI as a marker for hepatic fibrosis and inflammation in patients with primary sclerosing cho...
Autores principales: | Keller, Sarah, Aigner, Annette, Zenouzi, Roman, Kim, Anne C., Meijer, Arnoud, Weidemann, Sören A., Krech, Till, Lohse, Ansgar W., Adam, Gerhard, Schramm, Christoph, Yamamura, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841815/ https://www.ncbi.nlm.nih.gov/pubmed/29513767 http://dx.doi.org/10.1371/journal.pone.0193929 |
Ejemplares similares
-
Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis
por: Schulze, Kornelius, et al.
Publicado: (2015) -
Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis
por: Ehlken, Hanno, et al.
Publicado: (2016) -
Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis
por: Peiseler, Moritz, et al.
Publicado: (2018) -
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
por: Rühlemann, Malte, et al.
Publicado: (2019) -
Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida species
por: Rühlemann, Malte Christoph, et al.
Publicado: (2020)